Journey Medical (DERM) Other Non Operating Income (2021 - 2026)
Journey Medical (DERM) posted Other Non Operating Income of -$3000.0 for Q1 2026, up 98.54% on a QoQ basis from -$206000.0 in Q4 2025, and up 57.14% year-over-year from -$1909.1 in Q1 2025.
Journey Medical (DERM) Other Non Operating Income (2021 - 2026) Analysis & Trends
Journey Medical's Other Non Operating Income history runs 6 years deep, the most recent figure standing at -$3000.0 for Q1 2026.
- Quarterly Other Non Operating Income rose 57.14% year-over-year to -$3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$273000.0 (down 125.14% YoY) and the FY2025 annual result came in at -$277000.0, down 124.62% from the prior year.
- Other Non Operating Income was -$3000.0 for Q1 2026 at Journey Medical, up from -$206000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.1 million in Q3 2024 and bottomed at -$206000.0 in Q4 2025.
- A 5-year average of $37142.9 and a median of -$27000.0 in 2022 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income slumped 1000.0% — and 2024, when it surged 1213.86%.
- Journey Medical's Other Non Operating Income stood at -$67000.0 in 2022, then surged by 97.01% to -$2000.0 in 2023, then soared by 56350.0% to $1.1 million in 2024, then tumbled by 118.31% to -$206000.0 in 2025, then surged by 98.54% to -$3000.0 in 2026.
- Business Quant data shows DERM's Other Non Operating Income at -$3000.0 in Q1 2026, -$206000.0 in Q4 2025, and -$3000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Journey Medical | 169.02 Mn | 141.80 Mn | 9.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -206,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -61,000.00 |
| Mar 31, 2025 | -7,000.00 |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | -32,000.00 |
| Mar 31, 2024 | -21,000.00 |
| Dec 31, 2023 | -2,000.00 |
| Sep 30, 2023 | -101,000.00 |
| Jun 30, 2023 | -33,000.00 |
| Mar 31, 2023 | -47,000.00 |
| Dec 31, 2022 | -67,000.00 |
| Sep 30, 2022 | -22,000.00 |
| Dec 31, 2021 | -263,000.00 |
| Sep 30, 2021 | -2,000.00 |
| Jun 30, 2021 | -182,000.00 |